Gilead Sciences (GILD)

Purchases of Investments

-$1.75B

TTM · Period ending: · USD

GILD logo

GILD Purchases of Investments

Latest reported-$1.75B
GILD TTM Purchases of Investments (-$178.80M → -$1.75B)
High-resolution chart · PNG

GILD purchases of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Gilead Sciences Purchases of Investments — Trailing twelve months (TTM) (USD)
Period endingPurchases of Investments (USD)
-1,748,000,000
-4,600,000,000
-4,072,000,000
-2,715,000,000
-2,372,000,000
-98,000,000
-736,000,000
-1,377,000,000
-1,763,000,000
-2,374,000,000
-2,372,000,000
-2,070,000,000
-2,105,000,000
-1,953,000,000
-1,942,000,000
-2,238,000,000
-2,652,000,000
-3,328,000,000
-3,897,000,000
-3,796,000,000
-6,310,000,000
-8,814,000,000
-20,770,000,000
-27,117,000,000
-31,941,000,000
-38,616,000,000
-32,228,000,000
-30,101,000,000
-25,828,000,000
-17,092,000,000
-10,711,000,000
-10,419,000,000
-12,054,000,000
-20,229,000,000
-23,314,000,000
-24,551,000,000
-26,866,000,000
-24,124,000,000
-25,976,000,000
-25,186,000,000
-22,771,000,000
-20,111,000,000
-17,239,000,000
-12,883,574,000
-8,321,574,000
-4,492,574,000
-2,124,574,000
-1,534,043,000
-707,343,000
-288,096,000
-256,700,000
-350,804,000
-837,177,000
-1,307,502,000
-1,269,898,000
-2,140,219,000
-3,045,778,000
-3,633,648,000
-5,127,790,000
-5,863,729,000
-6,200,626,000
-5,519,054,000
-5,502,687,000
-4,497,828,000
-3,439,920,000
-3,237,382,000
-2,614,046,000
-2,938,363,000
-3,155,789,000
-3,493,589,000
-3,273,112,000
-3,252,747,000
-3,133,830,000
-3,341,040,000
-3,507,119,000
-2,791,059,000
-2,699,435,000
-2,390,147,000
-2,609,483,000
-3,483,018,000
-3,057,019,000
-2,778,908,000
-2,225,980,000
-1,457,287,000
-1,607,921,000
-1,590,289,000
-1,464,046,000
-1,273,024,000
-1,076,135,000
-992,835,000
-934,759,000
-914,207,000
-773,441,000
-673,977,000
-490,259,000
-410,448,000
-360,312,000
-343,341,000
-377,725,000
-378,281,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.